bezafibrate has been researched along with thyroxine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bismuth, J; Bonne, J; Gharbi-Chihi, J; Teboul, M; Torresani, J | 1 |
| Kobayashi, J; Morisaki, N; Murano, S; Saito, Y; Tashiro, J; Yamazaki, K | 1 |
| Bar-Shalev, A; Bar-Shalom, R; Frenkel, A; Israel, O; Keidar, Z; Rispler, S; Strauss, HW; Weiler-Sagie, M | 1 |
| Brandão, CJ; de Souza, RC; Dos Santos, TL; Godoy, AA; Kummrow, F; Pinto, E | 1 |
| Fujii, T; Hakata, T; Hanaoka, I; Hirota, K; Inagaki, N; Sakane, Y; Sugawa, T; Tagami, T; Ueda, Y; Usui, T; Yamashita, T; Yamauchi, I; Yasoda, A | 1 |
6 other study(ies) available for bezafibrate and thyroxine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increase of adipose differentiation by hypolipidemic fibrate drugs in Ob 17 preadipocytes: requirement for thyroid hormones.
Topics: Adipose Tissue; Animals; Bezafibrate; Cell Differentiation; Cell Line; Cell Nucleus; Clofibrate; Fenofibrate; Gene Expression Regulation; Hypolipidemic Agents; Mice; Mice, Obese; Receptors, Thyroid Hormone; Thyroid Hormones; Thyroxine | 1993 |
Type III hyperlipidaemia with primary hypothyroidism: a unique clinical course of hyperlipidaemia during replacement therapy of thyroid hormone.
Topics: Aged; Bezafibrate; Cholesterol; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Hypothyroidism; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Thyroxine; Triglycerides | 1997 |
PET/CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake.
Topics: Adult; Aged; Aged, 80 and over; Aging; Benzodiazepines; Bezafibrate; Diabetes Mellitus; Drug Interactions; Female; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Hypolipidemic Agents; Male; Middle Aged; Multivariate Analysis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Thyroxine; Tomography, X-Ray Computed; Whole-Body Counting | 2007 |
Occurrence of caffeine, fluoxetine, bezafibrate and levothyroxine in surface freshwater of São Paulo State (Brazil) and risk assessment for aquatic life protection.
Topics: Bezafibrate; Brazil; Caffeine; Environmental Monitoring; Fluoxetine; Fresh Water; Risk Assessment; Thyroxine; Water Pollutants, Chemical | 2021 |
Bezafibrate induces hypothyroidism in a patient with resistance to thyroid hormone β due to a G347R variant.
Topics: Animals; Bezafibrate; HEK293 Cells; Humans; Hypothyroidism; Male; Mice; Retrospective Studies; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine | 2022 |